Tristan Edwards
Fondateur chez Life Biosciences, Inc.
Profil
Tristan Alexander Edwards is the founder of Life Biosciences, Inc. (founded in 2017) where he holds the title of President & Chief Investment Officer.
He is currently the Executive Chairman at Proto Axiom Pty Ltd., Director at JumpStart Fertility, Inc., Director at Senolytic Therapeutics, Inc., Director at Continuum Biosciences, Inc., and Director at Animal Biosciences, Inc. Mr. Edwards previously held the position of Chairman & Chief Investment Officer at Mosaic Asset Management LP from 2012 to 2014.
He was also a Non-Executive Director at Alterity Therapeutics Ltd.
from 2019 to 2022.
Additionally, he served as a Portfolio Manager at Trafalgar Capital Management (UK) LLP from 2007 to 2010.
Mr. Edwards received his undergraduate degree from the University of Tasmania.
Postes actifs de Tristan Edwards
| Sociétés | Poste | Début |
|---|---|---|
Life Biosciences, Inc.
 Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA. | Fondateur | 01/01/2017 |
Continuum Biosciences, Inc.
 Continuum Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Continuum Biosciences, Inc. operates as a biotech company that focuses on diseases such as obesity, diabetes, and ageing. The company was founded in 2017 and is headquartered in Blacksburg, VA. | Directeur/Membre du Conseil | - |
Animal Biosciences, Inc.
 Animal Biosciences, Inc. Food: Specialty/CandyConsumer Non-Durables Animal Biosciences, Inc. operates as a pre-commercialization and bio-pharmaceutical company. The firm develops therapeutics and supplements for pets, primarily dogs, cats and horses. The company was headquartered in Boston, MA. | Directeur/Membre du Conseil | - |
Senolytic Therapeutics, Inc.
 Senolytic Therapeutics, Inc. Medical/Nursing ServicesHealth Services Senolytic Therapeutics, Inc. engages in healthcare service. The company was founded in 2017 and is headquartered in Chestnut Hill, MA. | Directeur/Membre du Conseil | - |
JumpStart Fertility, Inc.
 JumpStart Fertility, Inc. Medical/Nursing ServicesHealth Services JumpStart Fertility, Inc. operates in the health care industry. The company is headquartered in Chestnut Hill, MA. | Directeur/Membre du Conseil | - |
Proto Axiom Pty Ltd.
 Proto Axiom Pty Ltd. BiotechnologyHealth Technology Proto Axiom Pty Ltd. is an Australian company that focuses on investing in pre-clinical biotech companies to expand the growing bioscience industry. The company is based in Melbourne, Australia. The company has a disciplined and repeatable approach to investing by centralizing a world-class R & D team and licensing leading scientific IP to commercialize it. The company has an executive leadership with over 40 years of experience and a world-renowned scientific team with education from top academic institutions from across the globe, including Harvard. Despite Australia's strong biotech credentials, there is a distinct lack of early-stage venture capital funds to support and commercialize this science. The company was founded in 2021, and the CEO is Anthony Liveris. | Président | - |
Anciens postes connus de Tristan Edwards
| Sociétés | Poste | Fin |
|---|---|---|
| ALTERITY THERAPEUTICS LIMITED | Directeur/Membre du Conseil | 04/01/2022 |
Mosaic Asset Management LP
 Mosaic Asset Management LP Investment ManagersFinance Mosaic Asset Management LP is a registered investment firm located in San Francisco. | Président | 01/10/2014 |
Trafalgar Capital Management (UK) LLP
 Trafalgar Capital Management (UK) LLP Investment ManagersFinance Trafalgar Capital Management (UK) LLP (Trafalgar UK) is an alternative investment manager headquartered in London, UK. The firm was founded by Christopher Aarons in 2001 and is wholly-owned by Trafalgar Capital Management Ltd. Trafalgar UK manages separate hedge-based strategies. | Gestionnaire de Portefeuille-Actions | 01/01/2010 |
| ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░ | - |
Formation de Tristan Edwards
| University of Tasmania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALTERITY THERAPEUTICS LIMITED | Health Technology |
| Entreprise privées | 9 |
|---|---|
Trafalgar Capital Management (UK) LLP
Trafalgar Capital Management (UK) LLP Investment ManagersFinance Trafalgar Capital Management (UK) LLP (Trafalgar UK) is an alternative investment manager headquartered in London, UK. The firm was founded by Christopher Aarons in 2001 and is wholly-owned by Trafalgar Capital Management Ltd. Trafalgar UK manages separate hedge-based strategies. | Finance |
Trafalgar Capital Management (HK) Ltd.
 Trafalgar Capital Management (HK) Ltd. Investment ManagersFinance Trafalgar Capital Management (HK) Ltd. (Trafalgar HK) is a boutique investment management firm headquartered in Hong Kong. Formerly known as Megajoy Global Ltd., the firm was founded in 2010 and is owned by Trafalgar International Group SA in British Virgin Islands. Trafalgar HK manages two separate Hedge based strategies. | Finance |
Life Biosciences, Inc.
Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA. | Electronic Technology |
Continuum Biosciences, Inc.
Continuum Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Continuum Biosciences, Inc. operates as a biotech company that focuses on diseases such as obesity, diabetes, and ageing. The company was founded in 2017 and is headquartered in Blacksburg, VA. | Commercial Services |
Animal Biosciences, Inc.
Animal Biosciences, Inc. Food: Specialty/CandyConsumer Non-Durables Animal Biosciences, Inc. operates as a pre-commercialization and bio-pharmaceutical company. The firm develops therapeutics and supplements for pets, primarily dogs, cats and horses. The company was headquartered in Boston, MA. | Consumer Non-Durables |
Senolytic Therapeutics, Inc.
Senolytic Therapeutics, Inc. Medical/Nursing ServicesHealth Services Senolytic Therapeutics, Inc. engages in healthcare service. The company was founded in 2017 and is headquartered in Chestnut Hill, MA. | Health Services |
JumpStart Fertility, Inc.
JumpStart Fertility, Inc. Medical/Nursing ServicesHealth Services JumpStart Fertility, Inc. operates in the health care industry. The company is headquartered in Chestnut Hill, MA. | Health Services |
Mosaic Asset Management LP
Mosaic Asset Management LP Investment ManagersFinance Mosaic Asset Management LP is a registered investment firm located in San Francisco. | Finance |
Proto Axiom Pty Ltd.
Proto Axiom Pty Ltd. BiotechnologyHealth Technology Proto Axiom Pty Ltd. is an Australian company that focuses on investing in pre-clinical biotech companies to expand the growing bioscience industry. The company is based in Melbourne, Australia. The company has a disciplined and repeatable approach to investing by centralizing a world-class R & D team and licensing leading scientific IP to commercialize it. The company has an executive leadership with over 40 years of experience and a world-renowned scientific team with education from top academic institutions from across the globe, including Harvard. Despite Australia's strong biotech credentials, there is a distinct lack of early-stage venture capital funds to support and commercialize this science. The company was founded in 2021, and the CEO is Anthony Liveris. | Health Technology |